NAPROXEN SODIUM
- Product NDC
- 61919-470
- 11-digit product format
- 619190470
- Labeler code
- 61919
- Product ID
- 61919-470_9ca98d44-03b7-f379-e053-2995a90a9cb9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA090545
- Marketing category
- ANDA
- Marketing start
- 2018-03-12
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-470-50 | 61919047050 | 50 TABLET in 1 BOTTLE (61919-470-50) | 50 tablet | 2018-03-12 | 0000-00-00 | No | No | Current |